MILLER RICHARD A MD
President and CEO
MILLER RICHARD A MD has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 20, 2026.
On the most recent filing, MILLER RICHARD A MD is listed as President and CEO at Corvus Pharmaceuticals, Inc. Inside the rolling window, MILLER RICHARD A MD reported 1 open-market purchase totaling $83K in CRVS and no open-market sales.
Companies traded
Other insiders at CRVS
Insider Buying
$83K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MILLER RICHARD A MD made?
MILLER RICHARD A MD has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does MILLER RICHARD A MD trade?
MILLER RICHARD A MD has filed SEC Form 4 disclosures for 1 company, including CRVS.
When was MILLER RICHARD A MD's most recent SEC Form 4 filing?
MILLER RICHARD A MD's most recent SEC Form 4 filing on Tracefour is dated May 20, 2026.
What is MILLER RICHARD A MD's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, MILLER RICHARD A MD is listed as President and CEO.
What is MILLER RICHARD A MD's total buy and sell value in the current window?
Inside the rolling retention window, MILLER RICHARD A MD bought $83K and sold $0 based on SEC Form 4 filings.
What was MILLER RICHARD A MD's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 6,932 CRVS shares on 2026-05-18, worth $83K, per SEC Form 4 filings.